Eyhance and the EDOF IOL Category: Where It Fits
Where Eyhance Fits in the EDOF Category
Per EyeWiki (2023), Tecnis Eyhance is grouped under the enhanced monofocal or beam-shaping EDOF subcategory of extended depth of focus IOLs. These lenses change the shape of the central optic. They widen depth of focus. They do this without splitting light. Multifocal lenses split light into separate points.
This makes Eyhance a kind of bridge lens. It sits between standard monofocals and full EDOF lenses. Patients gain a bit more useful range than a monofocal. They keep a halo profile close to a monofocal. It is much lower than a multifocal.
Per AAO EyeNet (2021), Eyhance does not meet FDA criteria as a true EDOF or multifocal. Near-range performance falls off too much. The lens is best described as a monofocal-plus design with an EDOF-like mid-range boost. The label matters because it sets the patient expectation.
True EDOF lenses give a longer range of useful vision. They often reach from far through mid-range into useful near. Multifocal lenses split focus into separate distance and near zones. Eyhance is a step short of either. It adds a small mid-range boost to a clean monofocal.
Per EyeWiki (2023), the two main beam-shaping enhanced monofocal IOLs in the U.S. market are Tecnis Eyhance and RayOne EMV. Both use shape-based optics rather than diffractive rings to extend depth of focus. Both target patients who want a small step beyond a standard monofocal. They want to avoid the halos of a multifocal.
Eyhance has been more widely studied in pivotal clinical trials and long-term follow-up. Surgeon familiarity in the U.S. market also leans toward Eyhance. Both options achieve similar mid-range goals through different optic designs.
Per the FDA Premarket Approval Database (2021), Eyhance entered the U.S. market through the Tecnis 1-piece platform, under PMA P980040 supplement series, in 2021. The platform itself has been used for prior Tecnis monofocals. The Eyhance optic is the new feature.
The path through a supplement to an existing PMA is a common route for an enhanced version of an established lens platform. The supplement adds new optical performance data. The base lens material and overall design were already approved.
How EDOF Lenses Differ From Other IOL Types
True EDOF lenses use diffractive rings or other features. They stretch a single focal point into a longer range. Per AAO consensus (post-2020), the EDOF category requires clinical studies of at least 100 patients showing at least 0.5 diopters of additional depth of focus. They also require that at least 50% of eyes achieve mid-range visual acuity of 20/32 or better at 66 cm.
Eyhance meets the depth-of-focus benchmarks set out in those guidelines. It does not meet the full FDA EDOF criteria because of the near-range falloff. Patients can think of it as a beam-shaping lens that delivers EDOF-like mid-range without a true EDOF near end.
Multifocal IOLs use diffractive rings. They split incoming light into two or three points. The patient sees clear images at many distances at once. The brain picks the right one. This gives the widest range of glasses-free vision. It also makes more halos and starbursts at night.
Eyhance does not split light. It shapes light. The result is a more natural-feeling visual experience that resembles monofocal vision at distance. The halos that come with diffractive lenses are not part of the Eyhance profile.
Standard monofocal IOLs focus light at a single distance, usually far. They give clear distance vision, very low halo rates, and predictable outcomes. Patients then use glasses for mid-range and near tasks. Standard monofocals remain the most-implanted IOL type by a wide margin.
Eyhance preserves the strengths of a standard monofocal at distance. It adds modest mid-range function. The trade-off is small. The optic design differs. The cost is often slightly higher. The low halo profile stays the same.
Patients who want the broadest possible glasses freedom should look at multifocals or full EDOF lenses. Patients who want the cleanest possible night vision should look at standard monofocals. Patients who want a useful mid-range gain without giving up the low halo feel often pick Eyhance.
The choice depends on lifestyle. It also depends on glasses-freedom goals and halo tolerance. Most surgeons review the trade-offs in detail during the preoperative talk.
How Eyhance Achieves Its EDOF-Like Effect
Per Mencucci and colleagues in the Journal of Cataract and Refractive Surgery (2020), the Eyhance optic uses a smooth aspheric front surface with no diffractive rings. The power profile increases gradually from the edge of the lens to the center. This produces approximately 0.5 diopters of additional depth of focus compared with a standard aspheric monofocal.
The key word is continuous. There is no abrupt change between zones because there are no separate zones. Light passing through the center is focused a bit closer than light passing through the edge. The brain then sees a slightly stretched depth of clear vision.
Diffractive rings split light by rules. The rules do not depend on pupil size or light. They work the same way in bright daylight and at night. The trade-off is a halo and starburst pattern. Some patients notice it in low light.
Beam-shaping optics behave more like the natural lens. They depend on the shape of light passing through. They do not create the same fixed halo geometry. This is why Eyhance halo rates are similar to standard monofocals, not multifocals.
The added depth of focus is modest in absolute terms. 0.5 diopters is a small number on a refraction chart. In daily life it means seeing the dashboard, a computer screen, or a kitchen counter without glasses. For many patients, that small change covers a large fraction of common daily tasks.
The benefit is most clear at distances around 60 to 80 centimeters from the eye. Closer than that, the optic performance falls off. Farther than that, distance vision is already excellent without the boost.
Who Is a Good Candidate
Per AAO patient education (2023), all premium IOLs share a basic candidacy profile. The patient should have regular corneal astigmatism or accept a toric variant. They should also have a healthy macula, accurate biometry, and fair expectations. Eyhance fits this same profile.
Patients who do not meet these basic criteria are usually better served by a standard monofocal. The surgeon talks through the findings at the preop visit. They explain why a given option is or is not a good fit.
Eyhance suits patients whose main goal is mid-range glasses freedom, not near glasses freedom. They want to see a computer, a dashboard, or a kitchen counter without glasses. They are usually fine with readers for fine print.
Patients who want to read a paperback without glasses should look at EDOF or multifocal options. The trade-off is more halos. The Eyhance design does not deliver glasses-free reading.
Bad uncorrected corneal astigmatism blurs vision after cataract surgery, no matter which IOL is used. Patients with regular astigmatism above about 0.75 diopters often benefit from a toric IOL or small relaxing incisions. The toric Eyhance puts the enhanced optic and astigmatism correction in one lens.
Patients with irregular astigmatism, such as from keratoconus or scarring, may not be fully helped by a toric. The surgeon discusses alternatives if topography shows irregularity.
The macula must be healthy to gain the full benefit of a premium IOL. Issues such as macular degeneration, prior macular swelling, or epiretinal membrane can limit the gain. Some patients with these conditions still choose Eyhance after a thorough discussion.
Macular OCT is now a routine part of premium IOL planning. The scan finds subtle issues an eye exam alone might miss. Identifying them early helps set fair expectations.
Preoperative Testing
Per EyeWiki (2023), Eyhance planning starts with biometry. Biometry measures the axial length, the cornea shape, and the depth of the front chamber. These numbers feed a formula that picks the right lens for the patient.
Modern optical biometry uses light to measure the eye. It is far more accurate than older ultrasound methods. Accurate biometry is the single biggest factor in a good outcome with any premium lens.
Topography maps the cornea front surface. It finds regular astigmatism that can be fixed with a toric Eyhance. It also rules out irregular astigmatism. That would limit the outcome of any IOL.
Patients with prior LASIK or PRK have altered corneal shapes. Special formulas adjust for these effects. Topography helps the surgeon pick the right one.
An OCT scan of the macula is often done before surgery for any premium IOL. The scan can find subtle issues such as early epiretinal membrane or vitreomacular traction. These can limit the lens benefit.
If the macula is not healthy, the surgeon may suggest a standard monofocal. The talk is honest. A premium lens cannot overcome a retinal limit.
The preoperative talk is the most important part of premium IOL planning. Patients are asked about daily tasks, work, hobbies, and where they most want to be glasses-free. The surgeon then matches those goals to lens options.
Patients who arrive with strong preferences are heard. Patients who want guidance get a detailed review of the trade-offs. The decision is collaborative.
Visual Outcomes From Pivotal Studies
Per Auffarth and colleagues (2021), pivotal studies showed Eyhance maintains 20/20 or better distance acuity. The enhanced optic does not compromise far vision. Patients can drive, watch TV, and recognize faces across a room without distance glasses, given that biometry targets were met.
This is one of the main reasons patients choose Eyhance over multifocal or full EDOF lenses. Multifocals and some EDOFs reduce contrast at distance because they split or stretch light. Eyhance preserves contrast at distance.
Per Auffarth and colleagues (2021), Eyhance improves uncorrected and distance-corrected mid-range visual acuity by approximately one logMAR line compared with monofocal controls. A logMAR line equals one row on a standard eye chart.
That one-line gain is the main practical benefit of the lens. It moves typical mid-range tasks from blurry without glasses to functional without glasses. Patients notice the difference at the computer and the kitchen counter.
A 5-year follow-up cohort by Garzon and colleagues (2025) reported that all patients maintained binocular uncorrected mid-range visual acuity of 0.2 logMAR or better. Glasses freedom at distance was 100%. Glasses freedom for mid-range tasks was greater than 75%.
The long-term data matter because IOLs are typically a lifelong choice. Stable performance over 5 years suggests the lens optic does not change in any clinically meaningful way. Patients can plan around stable visual outcomes.
The Eyhance design does not deliver glasses-free near vision. The near falloff is what keeps it from meeting full FDA EDOF criteria. Patients who try to read a paperback without readers usually find the print blurry.
Reading glasses for fine print remain part of life with Eyhance. Most patients accept this trade. The combination of clear distance, useful mid-range, and low halos at night feels like a fair package to them.
Halos and Side Effects
Dysphotopsia is the medical term for unwanted visual effects such as halos, glare, and starbursts. Per AAO EyeNet (2021), Eyhance produces dysphotopsia profiles statistically similar to standard monofocals. The rates are significantly lower than diffractive multifocal and trifocal lenses.
Most light artifacts that patients notice in the early weeks settle as the eye adapts. Patients who continue to bother should mention it at follow-up. The surgeon checks for treatable causes such as residual refractive error.
The low halo profile is one reason Eyhance is sometimes the lens of choice for patients who do extensive night driving. Multifocal lenses produce noticeable halos around oncoming headlights and distant streetlamps. The Eyhance design avoids that pattern.
Some night vision adaptation in the first weeks is normal. Most patients return to comfortable night driving within the first month or two.
Mild scratchiness, slight redness, and brief fluctuating vision in the first days are normal after cataract surgery with any IOL, including Eyhance. These resolve as the eye settles.
Patients use prescribed eye drops for several weeks to control inflammation and prevent infection. They wear a protective shield while sleeping for the first week. They avoid heavy lifting, swimming, and rubbing the eye.
When to See a Doctor
Per AAO patient education (2023), Eyhance recipients should follow standard post-cataract follow-up. They should contact their ophthalmologist immediately for sudden vision loss, severe pain, increasing redness, new flashes or floaters, or a curtain in the field of view. These symptoms can signal endophthalmitis, retinal detachment, or significant inflammation.
Same-day means the same day, not the next morning. The on-call line is the right contact if the office is closed. If neither is reachable and symptoms are severe, an emergency department visit is appropriate.
Eyhance patients follow the same postoperative schedule as patients with any other IOL. Typical visits occur at one day, one week, and one month after surgery. Vision is checked. The eye is examined for inflammation or other early issues.
Long-term annual or biannual eye exams catch the most common late effect: posterior capsule opacification. PCO is treated reliably with a brief in-office laser procedure.
Patients who feel their vision is not progressing as expected should report it at follow-up. Most concerns have manageable causes such as residual refractive error, dry eye, or capsule changes. Each has a defined treatment.
Patients should not assume that a problem will resolve on its own past the first month. A targeted exam usually finds the cause.
Common Questions About Eyhance and EDOF Lenses
No. Eyhance does not meet full FDA criteria as an EDOF lens because near-range performance falls off. The lens is grouped under the beam-shaping enhanced monofocal subcategory, which produces an EDOF-like mid-range boost without splitting light. Most surgeons describe it as a monofocal-plus rather than a true EDOF.
True EDOF lenses give a longer range of useful vision. They often reach from far through mid-range into useful near. They can produce more halos than Eyhance because they alter light differently. Patients who want the broadest range should consider a true EDOF and accept the halo trade-off. Patients who want a smaller mid-range gain with a cleaner halo profile should consider Eyhance.
The 0.5 diopter gain is small in clinical terms and meaningful in daily life. It moves the typical computer-screen distance from blurry without glasses to functional without glasses. Patients usually report that they can work at a desktop screen, read large print at arm length, and check the dashboard while driving without reaching for readers.
No. The Eyhance optic preserves distance acuity and contrast at rates similar to standard monofocals. Patients can drive comfortably at night, watch TV, and recognize faces across a room without distance glasses. This is one of the main advantages of the beam-shaping design over diffractive lenses.
Multifocal patients see clear images at multiple distances at once. The brain selects the relevant one. Multifocals also produce halos and starbursts around lights, especially at night. Eyhance patients see a continuous range from far through mid-range. They do not see the same halo geometry. The trade-off is that Eyhance does not deliver glasses-free reading.
Yes. The toric Eyhance combines astigmatism correction with the enhanced monofocal optic. Patients with regular corneal astigmatism who want a mid-range boost can get both benefits in one lens. The surgeon places the toric markers at a specific orientation in the eye to neutralize the corneal astigmatism.
Five-year follow-up data from Garzon and colleagues (2025) suggest yes. All patients maintained binocular uncorrected mid-range visual acuity of 0.2 logMAR or better. Distance glasses freedom was 100%. Mid-range glasses freedom was greater than 75%. The lens optic does not change over time. The capsule that holds the lens can develop cloudiness, but this is treated reliably with an office laser procedure.
Per AAO consensus guidelines, the EDOF category requires clinical studies of at least 100 patients. The studies must show at least 0.5 diopters of additional depth of focus. They must also show that at least 50% of eyes achieve mid-range visual acuity of 20/32 or better at 66 cm. Eyhance meets the depth-of-focus benchmark. It does not meet the full set of EDOF criteria because of the near-range falloff.
The Eyhance optic does not change over time. If visual needs shift years later, options include glasses, contacts, or, in rare cases, lens exchange. Posterior capsule opacification, the most common late issue, is treated reliably with a brief in-office laser procedure. Most patients adapt well over the years.
Talk to Our Cataract Team About Premium IOL Options
The right IOL choice depends on your eye health, lifestyle, and visual goals. Our office offers a complete preoperative evaluation that includes biometry, corneal topography, and macular imaging. We discuss EDOF and enhanced monofocal options in detail and answer your questions. Call our team to schedule a consultation.